CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 4, Issue 134, Pages 134ra62-134ra62
Publisher
American Association for the Advancement of Science (AAAS)
Online
2012-05-17
DOI
10.1126/scitranslmed.3003330
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function
- (2014) T. N. Golovina et al. JOURNAL OF IMMUNOLOGY
- Monoclonal antibody blockade of IL-2 receptor during lymphopenia selectively depletes regulatory T cells in mice and humans
- (2011) D. A. Mitchell et al. BLOOD
- Window of opportunity for daclizumab
- (2011) Kimberly S Schluns NATURE MEDICINE
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- Retinoic Acid and Rapamycin Differentially Affect and Synergistically Promote the Ex Vivo Expansion of Natural Human T Regulatory Cells
- (2011) Tatiana N. Golovina et al. PLoS One
- Regulatory T Cells
- (2010) Tatiana N. Golovina et al. CANCER JOURNAL
- Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
- (2010) J. F. M. Jacobs et al. CLINICAL CANCER RESEARCH
- Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis
- (2010) Lan-Feng Cao et al. CYTOMETRY PART A
- Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
- (2010) Daniel Wynn et al. LANCET NEUROLOGY
- Stability of the Regulatory T Cell Lineage in Vivo
- (2010) Y. P. Rubtsov et al. SCIENCE
- Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
- (2009) Andrew J. Rech et al. Annals of the New York Academy of Sciences
- Homeostasis of peripheral FoxP3+ CD4+ regulatory T cells in patients with early and late stage breast cancer
- (2009) Andrew J. Rech et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Plasticity of CD4+ FoxP3+ T cells
- (2009) Xuyu Zhou et al. CURRENT OPINION IN IMMUNOLOGY
- Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
- (2009) Ethan M. Shevach IMMUNITY
- Decrease of Foxp3+ Treg Cell Number and Acquisition of Effector Cell Phenotype during Lethal Infection
- (2009) Guillaume Oldenhove et al. IMMUNITY
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Anti-CD25 antibodies affect cytokine synthesis pattern of human dendritic cells and decrease their ability to prime allogeneic CD4+ T cells
- (2008) K. Mnasria et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
- Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration
- (2007) Erica L. Carpenter et al. JOURNAL OF NEUROIMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search